Posters & Presentations

The Oral Cholate Challenge Test Identifies the MASH Patients with ≥F3 Fibrosis with Greatest Hepatic Impairment Who Show the Most Benefit from Short-term Rencofilstat Therapy

S. Harrison, Patrick Mayo, Todd Hobbs, Daren Ure, Robert Foster, M.P. McRae, G.T. Everson | AASLD | November 2024

Presentation Image